A patient with a diagnosis of acute decompensated heart failure is being treated with an intensified diuretic regimen and potassium supplementation. The nurse is educating the patient on signs of worsening heart failure. Which patient statement indicates a need for further teaching?

B) 'If I become short of breath while resting, I should increase my diuretic dose on my own.'

A) 'I should contact my healthcare provider if I gain more than 2 pounds in a day.'

B) 'If I become short of breath while resting, I should increase my diuretic dose on my own.'

C) 'I need to monitor my daily weight and keep a record for my next appointment.'

D) 'Reducing my salt intake will help prevent fluid buildup.'

A patient with heart failure presents with pulmonary congestion, jugular venous distention, ascites, an S3 gallop, elevated BNP, and hypokalemia. Which nursing intervention should be prioritized to prevent potential complications in this patient?

C) Educate the patient on taking daily weights and reporting a gain of more than 3 pounds in two days.

A) Administer potassium supplements as prescribed.

B) Encourage the patient to increase fluid intake to prevent dehydration.

C) Educate the patient on taking daily weights and reporting a gain of more than 3 pounds in two days.

D) Monitor the patient's lung sounds every 8 hours to assess for changes.

A patient with exacerbated heart failure presents with increased fatigue, shortness of breath, and decreased oxygen saturation. Vital signs indicate hemodynamic instability. Which of the following nursing interventions should take priority to address the patient's current condition?

A) Administer supplemental oxygen to maintain adequate oxygenation.

B) Increase diuretic dosage to reduce pulmonary congestion.

C) Initiate inotropic therapy to enhance cardiac output.

D) Encourage the patient to rest and restrict physical activity.

A patient with new-onset atrial fibrillation and rapid ventricular response is being treated with an intravenous diltiazem infusion. The patient has borderline hypotension and renal impairment. What is the primary nursing consideration when administering diltiazem in this scenario?

A) Monitor blood pressure closely to prevent severe hypotension.

B) Initiate anticoagulation therapy immediately to prevent thromboembolism.

C) Administer a loading dose of diltiazem to achieve rapid rate control.

D) Increase the diltiazem infusion rate if the heart rate does not decrease promptly.

A patient with newly diagnosed atrial fibrillation and rapid ventricular response is started on an intravenous diltiazem infusion for rate control. The nurse notes that the patient's blood pressure has dropped to 85/60 mmHg. Which of the following actions should the nurse take first?

A) Decrease the diltiazem infusion rate.

B) Administer a fluid bolus of normal saline.

C) Notify the healthcare provider immediately.

D) Apply oxygen via nasal cannula.

A patient with atrial fibrillation is receiving a diltiazem infusion to control heart rate. The patient's serum potassium level has dropped to 3.2 mEq/L. What is the priority nursing action in managing this patient?

B) Administer potassium supplementation as prescribed to correct hypokalemia.

A) Increase the rate of the diltiazem infusion to improve heart rate control.

B) Administer potassium supplementation as prescribed to correct hypokalemia.

C) Reduce the diltiazem infusion and monitor for signs of hypotension.

D) Initiate anticoagulation therapy to prevent thromboembolic events.

A patient with atrial fibrillation on a diltiazem infusion is experiencing borderline hypotension and hypokalemia. What is the priority nursing intervention to ensure patient stability?

B) Administer prescribed potassium supplements and closely monitor serum potassium levels.

A) Increase the diltiazem infusion rate to maintain heart rate control.

B) Administer prescribed potassium supplements and closely monitor serum potassium levels.

C) Discontinue the diltiazem infusion to prevent further hypotension.

D) Initiate a fluid bolus to address the borderline hypotension.

A patient with persistently low serum potassium levels and worsening renal function is being managed with adjusted diltiazem infusion and conservative anticoagulation. Which of the following nursing interventions is most important to prioritize in this scenario?

C) Monitor and document urine output hourly to assess renal perfusion.

A) Administer potassium supplements via oral route to enhance absorption.

B) Encourage increased oral fluid intake to promote kidney function.

C) Monitor and document urine output hourly to assess renal perfusion.

D) Educate the patient on the signs of hyperkalemia to ensure timely reporting.

A patient with a persistently low serum potassium level, rising serum creatinine, and decreased urine output is being treated with diltiazem. Which nursing intervention is most appropriate to prioritize for this patient?

B) Strictly monitor intake and output to assess fluid balance and adjust fluid therapy.

A) Increase oral potassium supplementation and encourage high-potassium foods.

B) Strictly monitor intake and output to assess fluid balance and adjust fluid therapy.

C) Administer a diuretic to improve urine output and facilitate potassium excretion.

D) Educate the patient on the importance of reducing physical activity to conserve energy.

Heart failure - Nursing Case Study

Pathophysiology

• Primary mechanism: Impaired cardiac contractility reduces the heart's ability to pump effectively, leading to decreased cardiac output and inadequate perfusion of tissues. This is often due to myocardial damage from conditions like ischemic heart disease or hypertension.

• Secondary mechanism: Compensatory mechanisms, such as the activation of the renin-angiotensin-aldosterone system (RAAS), initially help maintain cardiac output but eventually cause fluid retention and increased vascular resistance, worsening heart failure.

• Key complication: Fluid overload due to compensatory mechanisms can lead to pulmonary congestion and edema, causing symptoms like shortness of breath and decreased exercise tolerance, highlighting the importance of managing fluid balance in heart failure patients.

Patient Profile

Demographics:

68-year-old male, retired factory worker

History:

• Key past medical history: Hypertension, type 2 diabetes, coronary artery disease, previous myocardial infarction

• Current medications: Lisinopril, Metformin, Metoprolol, Aspirin, Simvastatin, Furosemide

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing shortness of breath and fatigue

• Key symptoms: Dyspnea on exertion, paroxysmal nocturnal dyspnea, ankle edema, weight gain, persistent cough

• Vital signs: Blood pressure 150/95 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, oxygen saturation 92% on room air, temperature 98.6°F

Section 1

As the medical team conducts an initial assessment, further examination reveals crackles in the lower lung fields bilaterally, suggesting pulmonary congestion. Jugular venous distention is noted, indicating elevated central venous pressure. The patient's abdomen is slightly distended, and he reports occasional nausea, potentially pointing to ascites and hepatic congestion. A focused cardiac exam demonstrates an S3 gallop, which is often associated with heart failure and suggests increased fluid volume and pressure in the heart.

Laboratory tests provide additional insights into the patient's condition. A BNP (B-type natriuretic peptide) level is significantly elevated at 1200 pg/mL, supporting the diagnosis of heart failure exacerbation. Renal function tests reveal a creatinine level of 1.8 mg/dL, indicating a decline in kidney function, likely due to renal hypoperfusion and effects of chronic diuretic therapy. Electrolyte imbalances are present, with a potassium level of 3.0 mEq/L, raising concerns for potential arrhythmias and necessitating careful monitoring and adjustment of diuretic therapy.

Given these findings, the healthcare team decides to adjust the patient’s treatment plan. The diuretic regimen is intensified, and potassium supplementation is initiated to correct the hypokalemia. A low-sodium diet is reinforced to help manage fluid overload. The patient is educated on the importance of daily weight monitoring to detect early signs of fluid retention. Despite these interventions, the medical team remains vigilant, as the risk of acute decompensated heart failure persists, requiring close observation for any further changes in the patient's status.

Section 2

Several days into the revised treatment plan, the patient's condition begins to shift, warranting close attention from the medical team. Upon morning assessment, the patient reports increased fatigue and shortness of breath with minimal exertion, suggesting a potential change in cardiac status. Vital signs reveal a blood pressure of 104/68 mmHg, heart rate of 110 beats per minute, and respiratory rate of 24 breaths per minute, indicating possible hemodynamic instability and respiratory compromise. Oxygen saturation has decreased to 88% on room air, prompting the need for supplemental oxygen to maintain adequate levels. Auscultation of the lungs continues to reveal bilateral crackles, now extending to the mid-lung fields, signifying worsening pulmonary congestion.

In light of these symptoms, a repeat chest X-ray is ordered and shows increased pulmonary vascular congestion and mild bilateral pleural effusions. The patient's laboratory results indicate a rise in BNP to 1500 pg/mL, confirming further exacerbation of heart failure. Renal function has deteriorated, with serum creatinine climbing to 2.1 mg/dL, raising concerns over acute kidney injury secondary to worsening cardiac output and ongoing diuretic therapy. Electrolyte levels have slightly improved with potassium now at 3.5 mEq/L, but the patient remains at risk for electrolyte disturbances due to continued diuretic use.

Given the evolving clinical picture, the healthcare team deliberates on the next steps. An escalation in diuretic therapy is considered, but must be balanced with the risk of further renal impairment. Inotropic support is discussed to improve cardiac output and alleviate symptoms. The patient's fluid status is carefully monitored through daily weights and input-output measurements to guide ongoing treatment. The team also explores potential underlying causes, such as medication noncompliance or dietary indiscretion, that may have contributed to the decompensation. This evolving scenario requires careful clinical reasoning to adjust the therapeutic approach and prevent further complications in the patient's intricate journey with heart failure.

Section 3

As the medical team reviews the patient's latest diagnostic results, they identify a concerning trend in the patient's cardiac rhythm. A 12-lead ECG ordered earlier in the day reveals new-onset atrial fibrillation with a rapid ventricular response, which may be contributing to the patient's increased fatigue and shortness of breath. This arrhythmia represents a potential complication of the worsening heart failure and requires immediate attention to prevent further hemodynamic instability. The heart rate, previously recorded at 110 beats per minute, has now spiked to 130 beats per minute, exacerbating the patient's already compromised cardiac output and increasing myocardial oxygen demand.

In response to the new arrhythmia, the healthcare team considers initiating rate control therapy with a beta-blocker or calcium channel blocker, weighing the benefits of rhythm stabilization against the risk of further lowering the patient's blood pressure. Given the patient's borderline hypotension, an intravenous diltiazem infusion is cautiously started, aiming to titrate it to a therapeutic effect that balances rate control with maintaining adequate perfusion pressure. The decision to start anticoagulation is also debated, considering the increased risk of thromboembolism associated with atrial fibrillation, but it must be carefully weighed against the patient's renal impairment and potential bleeding risk.

The patient is closely monitored for response to these interventions, with frequent reassessments of vital signs, cardiac rhythm, and oxygenation status. As the team navigates these complexities, they remain vigilant for signs of further decompensation or new complications, such as worsening renal function or electrolyte imbalances. This dynamic situation demands ongoing clinical reasoning to adapt the treatment plan, ensuring that each decision aligns with the ultimate goal of stabilizing the patient and preventing further deterioration.

Section 4

As the healthcare team continues to monitor the patient's response to the diltiazem infusion, they observe a gradual improvement in heart rate control. The heart rate decreases to 100 beats per minute, suggesting that the rate control strategy is beginning to stabilize the patient's cardiac rhythm. However, the team remains cautious due to the patient's persistent borderline hypotension, with blood pressure readings averaging 90/60 mmHg. This delicate balance necessitates frequent reassessment to ensure that the patient maintains adequate perfusion without compromising cardiac output or precipitating further hemodynamic instability.

During a routine electrolyte panel, the lab results reveal a concerning drop in the patient's serum potassium level, now at 3.2 mEq/L, which is lower than the normal range. This hypokalemia poses a significant risk in the context of atrial fibrillation, as low potassium levels can exacerbate arrhythmias and further compromise the patient's cardiac stability. The team promptly initiates potassium supplementation, both orally and intravenously, to address this imbalance and prevent potential ventricular arrhythmias that could lead to more serious complications.

As the team addresses the electrolyte imbalance, they remain vigilant for any signs of worsening renal function, given the patient's existing renal impairment. Continuous monitoring of renal markers and fluid status is crucial, as any further decline could necessitate adjustments in medication dosing or the overall treatment strategy. The team's ability to anticipate and respond to these evolving challenges is critical in guiding the patient's care and achieving a more stable clinical status. Moving forward, the team plans to re-evaluate the patient's anticoagulation needs, considering both the decreased risk of thromboembolism with improved rate control and the ongoing concerns about renal function and bleeding risk.

Section 5

As the healthcare team continues to carefully manage the patient's complex condition, a new complication arises. Despite aggressive potassium supplementation, the patient's serum potassium level remains persistently low at 3.0 mEq/L during the next lab evaluation. Concurrently, the latest serum creatinine level has increased from 1.4 mg/dL to 1.8 mg/dL, indicating a potential decline in renal function. This change raises concerns about the patient's ability to excrete excess medications and maintain electrolyte balance. The patient's urine output has also decreased to less than 30 mL/hour, further suggesting worsening renal impairment.

In response to these developments, the team convenes to reassess the patient's medication regimen and fluid management strategy. They decide to adjust the diltiazem infusion to a lower rate in an effort to reduce the load on the kidneys, while still maintaining adequate heart rate control. Additionally, the team increases the frequency of serum electrolyte monitoring and renal function tests to detect any further deterioration promptly. The patient's fluid status is carefully evaluated, with adjustments made to intravenous fluid administration to optimize renal perfusion and support cardiovascular stability.

As the management plan evolves, the healthcare team revisits the patient's anticoagulation strategy. Given the increased risk of bleeding due to potential renal-induced coagulopathy, they opt for a more conservative approach, closely monitoring the patient's coagulation profile. The team also educates the patient and family about the importance of adhering to the treatment plan and reporting any new symptoms, such as unusual bruising or changes in urine output. Through these concerted efforts, the team aims to stabilize the patient's condition and minimize the risk of further complications, while remaining vigilant for any signs of clinical deterioration.